Fig. 7 (abstract P196).
Survival of C57 mice bearing B16OVA tumors and treated on day 6 post-implantation with either PBS, PDL1 blockade, OVA-targeting PeptiCRAd or the combination of PDL1-blockade and OVA-PeptiCRAd.
Fig. 7 (abstract P196). | Journal for ImmunoTherapy of Cancer